#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419001	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R1 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
2.	ALA4419002	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R4 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
3.	ALA4419003	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R7 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
4.	ALA4419004	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R8 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
5.	ALA4419005	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R10 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
6.	ALA4419006	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
7.	ALA4419007	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R38 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
8.	ALA4419008	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R44 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
9.	ALA4419009	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R3 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
10.	ALA4419010	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R5 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
11.	ALA4419011	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R9 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
12.	ALA4419012	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R13 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
13.	ALA4419013	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R16 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
14.	ALA4419014	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R39 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
15.	ALA4419015	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
16.	ALA4419016	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R41 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
17.	ALA4419017	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R42 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
18.	ALA4419018	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R43 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
19.	ALA4419019	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R45 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1	ALA4418912	cell-based format	Patent Bioactivity Data
20.	ALA4419020	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R46 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data